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Dear Editor-in-Chief  
 
Systematic reviews of medical evidence count as 
important part of research due to their robust-
ness and credibility and wide range of audience. 
Systematic reviews usually aim to answer a ques-
tion when there is no clear answer straightfor-
ward to make a decision based on, or the answers 
are controversial. Hence, the questioners, who 
may be same of authors or may not, make their 
best to accumulate all present evidence to reach a 
consensus so that results in evidence-based clini-
cal decision-making or evidence-informed 
policymaking. 
Meta-analysis is a statistical technique that helps 
to aggregate findings from a systematic review. In 
other words, meta-analysis helps to combine 
small samples of single studies into a compound 
study with a much bigger sample size. Such big-
ger sample size leads to much narrower confi-
dence interval around the mean and estimation 
that is so more precise is obtained. 
Researchers in many countries around the world 
conduct systematic reviews and publish the re-
sults in scientific journals which are among the 
main sources of evidence for policy and decision 
making. Such studies, especially ones with meta-
analyses, should be resulted from robust meth-
odologies and careful investigation of researchers 
otherwise may end with misleading information 
for whom use them for policy and decision-
making. We summarize a framework, based on 
scientific and logical structure, for conducting 
meta-analyses as follows: 
a) Not all systematic reviews end with meta-
analysis. If the interested data are not 
numbers, we cannot usually do meta-
analysis. Moreover, some numeric infor-
mation, such as prevalence of a disease 
across different provinces of a country, 
should not be accumulated if they are not 
comprehensive and exclusive or are relat-
ed to different years. There is more con-
sideration for conducting systematic re-
views discussed through next points. 
b) In all studies, meta-analysis should come 
from appropriate keywords, sensitive and 
specific search strategy, comprehensive 
search in related scientific databases and 
unpublished works (1). 
c) Meta-analysis should be conducted on 
studies selected based on precisely de-
fined inclusion and exclusion criteria. The 
criteria should be reported clearly to the 
readers (2). 
d) Studies selected for meta-analysis should 
pass certain quality criteria. Measuring the 
quality of the selected studies is very im-
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portant. The main purpose of this section 
is generally to investigate the reliability 
and validity of the selected studies. Cer-
tain tools are available to assess the 
quality of any kind of study. STROBE, 
CONSORT, CASP, JADAD, and 
MOOSE are among frequently used ones 
(3). 
e) Data extraction from the selected studies 
for the final analysis step should be ex-
plained as a complete process. The target 
data, standard forms for data extraction, 
number of reviewers who extract data 
parallelly and independently (to make 
sure that the extracted data are valid), and 
the consensus manner if the reviewers 
disagreed (4). 
f) Statistical analysis section is one of the 
important parts that explained clearly and 
accurately. First, the appropriate statistical 
method should be determined in terms of 
the type of model- random or fixed ef-
fect- and the rationale behind the selec-
tion. Any type of indicator including 
prevalence, relative risk, risk difference, 
odds ratio, mean difference, standard 
mean difference can be accumulated into 
a comprehensive mean (5). Confidence 
intervals and P-values also should be re-
ported where a mean is reported. How-
ever, heterogeneity of target indicators 
should be investigated, so that if data are 
heterogeneous statistically, aggregating 
them into a weighted mean should be 
avoided. Sometimes sub-group analysis 
can solve the problem of heterogeneity. 
To examine the heterogeneity Chi2 and 
I2, or Galbraith and Labbe plots can be 
used (6).  
g) To examine the changes of target indica-
tor over time cumulative meta-analysis 
can be which needs to sort the target 
measures chronologically from the oldest 
to the newest. 
h) One of main issues in meta-analysis is 
matter of outliers. If the results of one or 
a few of studies are significantly different 
than others’, there is sufficient justifica-
tion to re-check the quality of study. Sen-
sitivity analysis can resolve this issue as 
well (7).  
i) Finally to examine the publication bias 
Begg’s or Egger’s tests and funnel plot 
can be used (8).  
 
Conflict of interest 
 
The authors declare that there is no conflict of 
interest. 
 
References  
 
1. Khan KS, Kunz R, Kleijnen J, Antes G (2003). 
Five steps to conducting a systematic review. 
J R Soc Med, 96:118-21. 
2. Impellizzeri FM, Bizzini M (2012). Systematic 
review and meta-analysis: a primer. Int J Sports 
Phys Ther, 7:493–503. 
3. Gopalakrishnan S, Ganeshkumar P (2013). 
Systematic Reviews and Meta-analysis: 
Understanding the Best Evidence in Primary 
Healthcare. J Family Med Prim Care, 2:9–14. 
4. LeLorier J, Gregoire G, Benhaddad A, Lapierre 
J, Derderian F (1997). Discrepancies between 
meta‐ analyses and subsequent large 
randomized, controlled trials. N Engl J Med, 
337:536‐ 542. 
5. Tufanaru C, Munn Z, Stephenson M, 
Aromataris E (2015). Fixed or random effects 
meta-analysis? Common methodological 
issues in systematic reviews of effectiveness. 
Int J Evid Based Healthc, 13:196-207. 
6. Baker WL, White CM, Cappelleri JC et al (2009). 
Understanding heterogeneity in meta-analysis: 
the role of meta-regression. Int J Clin Pract, 
63:1426-34. 
7. Phan K, Tian DH, Cao C, Black D, Yan TD 
(2015). Systematic review and meta-analysis: 
techniques and a guide for the academic 
surgeon. Ann Cardiothorac Surg, 4:112–122. 
8. Egger M, Smith GD (1996). Bias in location and 
selection of studies. BMJ, 316:61-6. 
 
